Cantourage Group SE (FRA:HIGH)
| Market Cap | 36.16M |
| Revenue (ttm) | 1.95M |
| Net Income (ttm) | -95.53K |
| Shares Out | n/a |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | 72.33 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 22,457 |
| Average Volume | 318 |
| Open | 2.980 |
| Previous Close | 2.990 |
| Day's Range | 2.800 - 2.980 |
| 52-Week Range | 2.130 - 6.680 |
| Beta | n/a |
| RSI | 44.86 |
| Earnings Date | Apr 30, 2026 |
About Cantourage Group SE
Cantourage Group SE operates as a medical cannabis company in Europe. It offers dried flowers, extracts, dronabinol products, and pharma-grade cannabidiol products. The company was founded in 2019 and is based in Kleinmachnow, Germany. [Read more]
Financial Performance
In 2024, Cantourage Group SE's revenue was 2.20 million, an increase of 32.06% compared to the previous year's 1.66 million. Earnings were 79,293, an increase of 105.00%.
Financial StatementsNews
EQS-News: Cantourage strengthens market presence in Poland with flower variety “Gelato 33”
EQS-News: Cantourage Group SE / Key word(s): Expansion Cantourage strengthens market presence in Poland with flower variety “Gelato 33” 04.11.2025 / 12:00 CET/CEST The issuer is solely responsible for...
Cantourage Group Thrives in Q3 2025 Amid Regulatory Challenges
Cantourage Group SE is riding a wave of impressive growth, showcasing a remarkable 148% revenue surge. With strategic expansions and innovative offerings, Cantourage is redefining its market presence....
EQS-News: Q3 2025: Cantourage delivers strong operating performance in a challenging regulatory market environment
EQS-News: Cantourage Group SE / Key word(s): Quarter Results Q3 2025: Cantourage delivers strong operating performance in a challenging regulatory market environment 30.10.2025 / 10:08 CET/CEST The is...
EQS-News: Cantourage is responding to potential developments resulting from new legal regulations with focused internationalization and strategic product diversification
EQS-News: Cantourage Group SE / Key word(s): Market Report Cantourage is responding to potential developments resulting from new legal regulations with focused internationalization and strategic produ...
EQS-News: Cantourage Strengthens Capital Markets Presence: New Head of Investor Relations and Strategic Focus on Europe
EQS-News: Cantourage Group SE / Key word(s): Personnel Cantourage Strengthens Capital Markets Presence: New Head of Investor Relations and Strategic Focus on Europe 01.10.2025 / 09:47 CET/CEST The iss...
EQS-DD: Cantourage Group SE: Philip Schetter, Acquisition of 188,639 Shares as Part of a Capital Increase Against Contributions in Kind, Excluding Subscription Rights, at an Issue Price of EUR ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 01.10.2025 / 09:38 CET/CEST The issuer is solely responsi...
Original-Research: Cantourage Group SE (von NuWays AG): BUY • news
EQS-News: Cantourage Group SE Update • news
EQS-News: Cantourage Group SE / Schlagwort(e): Marktbericht Cantourage Group SE Update 04.09.2025 / 09:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeb…